Fundraising Fox
BeyondSpring Pharmaceuticals
3 known investors
Find your way into BeyondSpring Pharmaceuticals
Sign up to find every way you can get introduced to BeyondSpring Pharmaceuticals
- Your email: who you already know at BeyondSpring Pharmaceuticals, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BeyondSpring Pharmaceuticals team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.
Investors · 3
Frequently asked questions
- What does BeyondSpring Pharmaceuticals do?
- Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types. The compound demonstrates clinical benefit in extending overall survival and reducing severe chemotherapy-related neutropenia.
- Who are BeyondSpring Pharmaceuticals's investors?
- BeyondSpring Pharmaceuticals's investors include Decheng Capital, EFung Capital, Sangel Capital.